Corcept Therapeutics Incorporated <CORT.O>: Truist Securities assumes coverage with buy rating; target price $164 vs $50
CORT•Related News
TIC Solutions completes acquisitions of WDI, GeoVerra, Core Group
TIC•
US stock futures fall as fading Iran peace prospects drive up oil, yields
SPY•
Smith & Nephew CEO Deepak Nath’s restricted share vesting triggers GBP 513,423 share sale for taxes
SNN•
Essex Property Trust <ESS.N>: Deutsche Bank cuts target price to $325 from $330
ESS•
Stereolabs, Ouster subsidiary, partners with Trossen to integrate ZED X stereo cameras into Physical AI robot-learning platforms
OUST•